NYSE:CLB Core Laboratories Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Core Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. $19.61 -0.20 (-1.01%) (As of 07/1/2022 01:19 PM ET) Add Compare Share Today's Range$18.66▼$19.8750-Day Range$18.66▼$31.0252-Week Range$18.41▼$40.97Volume6,115 shsAverage Volume506,647 shsMarket Capitalization$908.10 millionP/E Ratio93.38Dividend Yield0.20%Price Target$29.43 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock Forecast (MarketRank)Overall MarketRank™2.35 out of 5 starsOils/Energy Sector116th out of 391 stocksOil & Gas Field Services, Not Elsewhere Classified Industry10th out of 32 stocksAnalyst Opinion: 2.7Community Rank: 3.9Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 - 2.7 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.33, and is based on no buy ratings, 1 hold rating, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.43, Core Laboratories has a forecasted upside of 50.2% from its current price of $19.59.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days. Previous Next 3.9 Community Rank Outperform VotesCore Laboratories has received 469 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCore Laboratories has received 337 “underperform” votes. (Add your “underperform” vote.)Community SentimentCore Laboratories has received 58.19% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote “Outperform” if you believe CLB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.20%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 19.05%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 2.99% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.42% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions92.56% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 94.20% in the coming year, from $0.69 to $1.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 93.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 43.15.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 93.29, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 13.47.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 5.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Core Laboratories (NYSE:CLB)Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.Read More CLB Stock News HeadlinesJune 28, 2022 | finance.yahoo.comCORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022June 22, 2022 | finance.yahoo.comWhy Shares in Core Labs Fell TodayJune 18, 2022 | americanbankingnews.comCore Laboratories (NYSE:CLB) Hits New 52-Week Low at $20.97June 9, 2022 | finance.yahoo.comWhy Core Labs Stock Dived by More Than 10% TodayJune 1, 2022 | finance.yahoo.comCore Laboratories Stock Generating Improved Relative StrengthMay 29, 2022 | finance.yahoo.comCore Laboratories' (NYSE:CLB) earnings have declined over five years, contributing to shareholders 71% lossMay 27, 2022 | nasdaq.comCLB Crosses Above Key Moving Average LevelMay 27, 2022 | finance.yahoo.comCore Laboratories (CLB) Up 2.6% Since Last Earnings Report: Can It Continue?May 9, 2022 | nasdaq.comCore Laboratories N.V. Shares Close the Day 12.1% Lower - Daily WrapMay 6, 2022 | finance.yahoo.comCore Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales BeatMay 6, 2022 | finance.yahoo.comA Look At The Fair Value Of Core Laboratories N.V. (NYSE:CLB)April 29, 2022 | finance.yahoo.comWhy Shares in Core Labs Fell This WeekApril 28, 2022 | seekingalpha.comCore Laboratories N.V. (CLB) CEO Larry Bruno on Q1 2022 Results - Earnings Call TranscriptSee More Headlines Industry, Sector and Symbol Stock ExchangeNYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(120) 420-3191FaxN/AEmployees3,700Year Founded1936Company Calendar Last Earnings4/27/2022Ex-Dividend for 5/31 Dividend5/06/2022Dividend Payable5/31/2022Today7/01/2022Next Earnings (Confirmed)7/27/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$29.43 High Stock Price Forecast$35.00 Low Stock Price Forecast$21.30 Forecasted Upside/Downside+50.1%Consensus RatingReduce Rating Score (0-4)1.33333333333333 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.21 Trailing P/E Ratio93.38 Forward P/E Ratio28.42 P/E GrowthN/ANet Income$19.73 million Net Margins2.04% Pretax Margin4.78% Return on Equity18.28% Return on Assets5.00% Debt Debt-to-Equity Ratio1.14 Current Ratio2.03 Quick Ratio1.54 Sales & Book Value Annual Sales$470.25 million Price / Sales1.93 Cash Flow$1.15 per share Price / Cash Flow17.10 Book Value$3.48 per share Price / Book5.64Miscellaneous Outstanding Shares46,308,000Free Float46,114,000Market Cap$908.10 million OptionableOptionable Beta2.71 Social Links Core Laboratories Frequently Asked Questions Should I buy or sell Core Laboratories stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" Core Laboratories stock. View analyst ratings for Core Laboratories or view top-rated stocks. What is Core Laboratories' stock price forecast for 2022? 3 Wall Street analysts have issued 12-month price objectives for Core Laboratories' stock. Their CLB stock forecasts range from $21.30 to $35.00. On average, they anticipate Core Laboratories' stock price to reach $29.43 in the next year. This suggests a possible upside of 50.6% from the stock's current price. View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts. How has Core Laboratories' stock performed in 2022? Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB stock has decreased by 12.4% and is now trading at $19.54. View the best growth stocks for 2022 here. When is Core Laboratories' next earnings date? Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022. View our earnings forecast for Core Laboratories. How can I listen to Core Laboratories' earnings call? Core Laboratories will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, April, 27th. The oil and gas company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.06 by $0.02. The oil and gas company had revenue of $115.30 million for the quarter, compared to the consensus estimate of $111.63 million. Core Laboratories had a net margin of 2.04% and a trailing twelve-month return on equity of 18.28%. During the same period in the previous year, the firm posted $0.15 earnings per share. View Core Laboratories' earnings history. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories announced a quarterly dividend on Wednesday, April 27th. Stockholders of record on Monday, May 9th will be paid a dividend of $0.01 per share on Tuesday, May 31st. This represents a $0.04 annualized dividend and a dividend yield of 0.20%. The ex-dividend date is Friday, May 6th. View Core Laboratories' dividend history. Is Core Laboratories a good dividend stock? Core Laboratories(NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio of Core Laboratories is 19.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 2.99% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. View Core Laboratories' dividend history. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories updated its first quarter 2022 earnings guidance on Wednesday, April, 13th. The company provided EPS guidance of $0.050-$0.080 for the period, compared to the consensus estimate of $0.200. The company issued revenue guidance of $110 million-$113 million, compared to the consensus revenue estimate of $110.23 million. Who are Core Laboratories' key executives? Core Laboratories' management team includes the following people: Mr. Lawrence V. Bruno, Chairman, CEO, Pres & COO (Age 62, Pay $1.61M)Mr. Christopher Scott Hill, Sr. VP & CFO (Age 52, Pay $702.65k)Ms. Gwendolyn Y. Gresham M.B.A., Sr. VP of Corp. Devel. & Investor Relations (Age 54, Pay $612.71k)Mr. Mark Damian Tattoli, Sr. VP, Sec. & Gen. Counsel (Age 50, Pay $948.9k)Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 58)Mr. Jacobus Schouten, Managing Director (Age 67)J. Donald Dumas Jr., Sr. VP of Production Enhancement & Bus. Devel. What is David M. Demshur's approval rating as Core Laboratories' CEO? 60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are some of Core Laboratories' key competitors? Some companies that are related to Core Laboratories include ProFrac (PFHC), Subsea 7 (SUBCY), Liberty Energy (LBRT), NexTier Oilfield Solutions (NEX), RPC (RES), Expro Group (XPRO), Oceaneering International (OII), ProPetro (PUMP), Select Energy Services (WTTR), National Energy Services Reunited (NESR), Helix Energy Solutions Group (HLX), North American Construction Group (NOA), Ranger Energy Services (RNGR), CSI Compressco (CCLP) and Hurricane Energy (HRCXF). View all of CLB's competitors. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD). What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." How do I buy shares of Core Laboratories? Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $19.54. How much money does Core Laboratories make? Core Laboratories (NYSE:CLB) has a market capitalization of $904.86 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.21 on an earnings per share basis. How many employees does Core Laboratories have? Core Laboratories employs 3,700 workers across the globe. When was Core Laboratories founded? Core Laboratories was founded in 1936. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for Core Laboratories is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected]. This page (NYSE:CLB) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here